![](/img/cover-not-exists.png)
Crystal structures of AKR1C3 containing an N-(aryl)amino-benzoate inhibitor and a bifunctional AKR1C3 inhibitor and androgen receptor antagonist. Therapeutic leads for castrate resistant prostate cancer
Mo Chen, Adegoke O. Adeniji, Barry M. Twenter, Jeffrey D. Winkler, David W. Christianson, Trevor M. PenningVolume:
22
Year:
2012
Language:
english
Pages:
6
DOI:
10.1016/j.bmcl.2012.03.085
File:
PDF, 1.24 MB
english, 2012